UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition

International journal of molecular sciences, 2020-04, Vol.21 (8), p.2721

2020

Volltextzugriff (PDF)

The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study

Journal of neuroinflammation, 2020-04, Vol.17 (1), p.133-18, Article 133

2020

Volltextzugriff (PDF)

Investigating clinical pharmacokinetics of brivaracetam by using a pharmacokinetic modeling approach

Scientific reports, 2024-06, Vol.14 (1), p.13357-12

2024

Volltextzugriff (PDF)

A pilot study of the moderating effect of gender on the physical activity and fatigue severity among recovered COVID-19 patients

PloS one, 2022-07, Vol.17 (7), p.e0269954

2022

Volltextzugriff (PDF)

Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases

Scientific reports, 2021-04, Vol.11 (1), p.8589-16, Article 8589

2021

Volltextzugriff (PDF)

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment

Pharmaceuticals (Basel, Switzerland), 2024-07, Vol.17 (7), p.924

2024

Volltextzugriff (PDF)

Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6219

2023

Volltextzugriff (PDF)

Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease

Scientific reports, 2023-02, Vol.13 (1), p.2697-2697, Article 2697

2023

Volltextzugriff (PDF)

A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide

Therapeutic drug monitoring, 2024-06, Vol.46 (3), p.309

2024

Volltextzugriff (PDF)

Ameliorative effect of Nyctanthes arbor-tristis L. by suppression of pentylenetetrazole-induced kindling in mice: An insight from EEG, neurobehavioral and in-silico studies

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116791, Article 116791

2024

Volltextzugriff (PDF)

Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11313

2021

Volltextzugriff (PDF)

Long-Term Supplementation of Syzygium cumini (L.) Skeels Concentrate Alleviates Age-Related Cognitive Deficit and Oxidative Damage: A Comparative Study of Young vs. Old Mice

Nutrients, 2023-01, Vol.15 (3), p.666

2023

Volltextzugriff (PDF)

A Semi-Physiological Three-Compartment Model Describes Brain Uptake Clearance and Efflux of Sucrose and Mannitol after IV Injection in Awake Mice

Pharmaceutical research, 2022-02, Vol.39 (2), p.251-261

2022

Volltextzugriff (PDF)

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

Frontiers in medicine, 2021-11, Vol.8, p.745789

2021

Volltextzugriff (PDF)

Tiagabine suppresses pentylenetetrazole-induced seizures in mice and improves behavioral and cognitive parameters by modulating BDNF/TrkB expression and neuroinflammatory markers

Biomedicine & pharmacotherapy, 2023-04, Vol.160, p.114406-114406, Article 114406

2023

Volltextzugriff (PDF)

Therapeutic Effects of Thymoquinone on Alzheimer's Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels

CNS & neurological disorders drug targets, 2023-01, Vol.22 (5), p.736

2023

Volltextzugriff (PDF)

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.265

2024

Volltextzugriff (PDF)

Sulforaphane treatment reverses corticosteroid resistance in a mixed granulocytic mouse model of asthma by upregulation of antioxidants and attenuation of Th17 immune responses in the airways

European journal of pharmacology, 2019-07, Vol.855, p.276-284

2019

Volltextzugriff (PDF)

Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7768

2024

Volltextzugriff (PDF)

Clinical pharmacokinetics of nadolol: A systematic review

Journal of clinical pharmacy and therapeutics, 2022-10, Vol.47 (10), p.1506-1516

2022

Volltextzugriff (PDF)

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer

Cancers, 2023-05, Vol.15 (10), p.2723

2023

Volltextzugriff (PDF)

LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose

Fluids and barriers of the CNS, 2020-10, Vol.17 (1), p.1-15, Article 61

2020

Volltextzugriff (PDF)

Unveiling the potential of perampanel and pregabalin in addressing pentylenetetrazole-induced electrographic alterations and neurobehavioral anomalies

Biomedicine & pharmacotherapy, 2024-01, Vol.170, p.115935-115935, Article 115935

2024

Volltextzugriff (PDF)

Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway

International journal of molecular sciences, 2022-06, Vol.23 (11), p.6260

2022

Volltextzugriff (PDF)

Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort

Journal of international medical research, 2022-04, Vol.50 (4), p.3000605221090363-3000605221090363

2022

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(147)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition

The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study

Investigating clinical pharmacokinetics of brivaracetam by using a pharmacokinetic modeling approach

A pilot study of the moderating effect of gender on the physical activity and fatigue severity among recovered COVID-19 patients

Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment

Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries

Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease

A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide

Ameliorative effect of Nyctanthes arbor-tristis L. by suppression of pentylenetetrazole-induced kindling in mice: An insight from EEG, neurobehavioral and in-silico studies

Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities

Long-Term Supplementation of Syzygium cumini (L.) Skeels Concentrate Alleviates Age-Related Cognitive Deficit and Oxidative Damage: A Comparative Study of Young vs. Old Mice

A Semi-Physiological Three-Compartment Model Describes Brain Uptake Clearance and Efflux of Sucrose and Mannitol after IV Injection in Awake Mice

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

Tiagabine suppresses pentylenetetrazole-induced seizures in mice and improves behavioral and cognitive parameters by modulating BDNF/TrkB expression and neuroinflammatory markers

Therapeutic Effects of Thymoquinone on Alzheimer's Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia

Sulforaphane treatment reverses corticosteroid resistance in a mixed granulocytic mouse model of asthma by upregulation of antioxidants and attenuation of Th17 immune responses in the airways

Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)

Clinical pharmacokinetics of nadolol: A systematic review

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer

LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose

Unveiling the potential of perampanel and pregabalin in addressing pentylenetetrazole-induced electrographic alterations and neurobehavioral anomalies

Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway

Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort

Suchergebnisse filtern